KOLON LIFE SCIENCE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22,050 KRW | -0.45% |
|
-1.12% | -14.20% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
KOLON LIFE SCIENCE Inc. is a Korea-based company mainly engaged in the manufacturing of functional materials. The Company operates its business under two segments. The Chemical Business segment produces and sells raw drug products, which are the raw materials of new drugs and generic drugs, antibacterial agents that suppress bacterial growth, water treatment agents for environmental purification, and functional material products for cosmetics. The Bio Business segment manufactures and sells bio new medicines based on cell gene therapy products.
Sector
Pharmaceuticals
Calendar
2025-05-13
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.20% | 186M | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- A102940 Stock
- News Kolon Life Science Inc.
- Kolon Life Science Enters $600 Million Deal to License out Gene Therapy Drug to Singapore's Juniper Biologics
